News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Real-world data to describe myeloma management and outcomes
Photo taken from Mohamad Mohty/X
Aug 1, 2024, 04:58

Real-world data to describe myeloma management and outcomes

Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne University, shared a post on X about a recent paper by Olivier Decaux et al., commenting:

“The EMMY longitudinal, cohort study by the IFM: real-world data to describe myeloma management and outcomes, published in Clinical Hematology International, the official peer-reviewed open access academic journal of The International Academy for Clinical Hematology (IACH).
No submission or other hidden fees.”

The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge published in Clinical Hematology International.

Authors: Olivier Decaux, Ronan Garlantézec, Karim Belhadj-Merzoug, Margaret Macro, Laurent Frenzel, Aurore Perrot, Philippe Moreau, Bruno Royer, Denis Caillot, Xavier Leleu, Mohamad Mohty, Lionel Karlin, Pierre Feugier, Sophie Rigaudeau, Jean Fontan, Cécile Sonntag, Laure Vincent, Thomas Chalopin, Herve Avet Loiseau, Zakaria Maarouf, Louni Chanaz, Nathalie Texier, Cyrille Hulin. 

Mohamad Mohty

Additional information
Source: Mohamad Mohty/X

Aurore Perrot Bruno Royer cancer Cécile Sonntag Clinical Hematology International Cyrille Hulin Denis Caillot Hervé Avet-Loiseau Jean Fontan Karim Belhadj-Merzoug Laure Vincent Laurent Frenzel Lionel Karlin Louni Chanaz Margaret Macro Mohamad Mohty Myeloma Nathalie Texier Olivier Decaux OncoDaily Oncology Philippe Moreau Pierre Feugier Ronan Garlantézec Sophie Rigaudeau Thomas Chalopin Xavier Leleu Zakaria Maarouf
Special Coverage
Career
Dec 7, 2024, 12:28
Honored to welcome Karen Knudsen to our board of directors - Exai Bio
Insight
Dec 7, 2024, 12:17
Art That Inspires Change - Richi Art Gallery
Blog
Dec 7, 2024, 11:45
Al-Ola A Abdallah: Celebrating mentees matching in Heme-Onc Fellowship
Blog
Dec 7, 2024, 11:26
Clement Fourny: Smart Labs had the privilege of hosting the 11th Catalysts cohort of Richi Entrepreneurs
Insight
Dec 7, 2024, 11:15
First hit on Autologous Stem Cell Transplantation in Mantle cell lymphoma
Blog
Dec 7, 2024, 11:11
Important factors associated with risk of developing melanoma in Rhode Island by Oliver Wisco
Blog
Dec 7, 2024, 11:11
Anirban Maitra: Comprehensive insights into KRAS signaling
Blog
Dec 7, 2024, 11:09
Matteo Lambertini: First ESMOYOC session at ESMO Asia 2024
Blog
Dec 7, 2024, 11:04
Lorenza Rimassa: Patient Advocate on Immunotherapy Choices in HCC and NSCLC at ESMO Asia 2024
Blog
Dec 7, 2024, 10:51
Vincenzo Corbo: MAPKhigh myCAF phenotype linked to immunotherapy resistance
Insight
Dec 7, 2024, 10:48
Use of the ESMO-Magnitude of Clinical Benefit Scale for HTA Recommendations
Blog
Dec 7, 2024, 10:47
Rational CAR design for augmented T cell function - Journal for ImmunoTherapy of Cancer